No Published Human Trials: There are no robust, large-scale human clinical trials showing BPC 157 can safely induce or maintain clinical remission in IBD
Why This Matters for Researchers Modern research peptide quality control should go beyond simple marketing claims
We live and breathe the science of peptide synthesis, purity, and stability
W., Feskens, K., Busschbach, J
In general, the most distinct clinical features (summarized in Table 1 ) include: (i) a recognizable orofacial gestalt at birth with swelling of the periorbital soft tissues, blue sclerae, down-slanting palpebral fissures, epicanthic folds, micrognathia, delayed fontanel closure, and dental anomalies in childhood and adulthood